UK AI for Predicting Pandemics and Global Health Emergencies Market - Strategic Insights and Forecasts (2026-2031)

The UK AI for Predicting Pandemics and Global Health Emergencies market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 15.2%. It is projected to reach USD 380.1 million in 2031, increasing from USD 187.4 million in 2026, indicating significant expansion driven by strategic investments and accelerating adoption.

Key growth drivers include accelerating Public Health Agency Adoption, with bodies like UKHSA trialling LLMs for real-time disease surveillance, and the UK Government's focus on prevention and digital infrastructure, as committed in the '10 Year Health Plan for England'. Additionally, a maturing regulatory framework is building trust and accelerating market readiness for AI solutions.

The Pharmaceutical and Biotech End-User segment is a high-value niche, primarily driven by UK AI startups leveraging proprietary AI platforms for next-generation vaccine design against future viral variants. Public health agencies, such as the UKHSA, also demonstrate an immediate need for sophisticated Outbreak Prediction & Detection and Disease Surveillance software by deploying AI projects for real-time analysis.

UK-based AI startups are leading innovators in next-generation vaccine design, utilizing proprietary AI platforms to analyze genomic, proteomic, and epidemiological data. This capability allows them to design synthetic antigens for predicting and protecting against future viral variants, creating significant high-value demand within the Pharmaceutical and Biotech End-User segment.

The establishment of the National Commission into the Regulation of AI in Healthcare and the UK's pioneering role in the HealthAI Global Regulatory Network signal a proactive approach to safety and efficacy. This maturation of the regulatory framework is crucial for building confidence and accelerating the market readiness for advanced AI solutions within public health and biosecurity.

AI is positioned as an imperative for public health resilience, shifting from an auxiliary research tool to a core component of the country’s biosecurity infrastructure. The market represents a 'high-stakes intersection of computational science and national security,' where strategic private investment and governmental procurement prioritize predictive accuracy and operational scale to preempt and manage global health emergencies.